Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer

光热治疗 佐剂 免疫系统 癌症研究 癌细胞 多西紫杉醇 癌症 PLGA公司 联合疗法 细胞毒性T细胞 纳米颗粒 免疫疗法 癌症免疫疗法 医学 化学 免疫学 药理学 材料科学 内科学 体外 纳米技术 生物化学
作者
Qiaoqi Chen,Liang Zhang,Lin Li,Mixiao Tan,Weiwei Liu,Shilin Liu,Zhuoyan Xie,Wei Zhang,Zhigang Wang,Yang Cao,Tingting Shang,Haitao Ran
出处
期刊:Journal of Nanobiotechnology [BioMed Central]
卷期号:19 (1) 被引量:35
标识
DOI:10.1186/s12951-021-01202-x
摘要

Mono-therapeutic modality has limitations in combating metastatic lesions with complications. Although emerging immunotherapy exhibits preliminary success, solid tumors are usually immunosuppressive, leading to ineffective antitumor immune responses and immunotherapeutic resistance. The rational combination of several therapeutic modalities may potentially become a new therapeutic strategy to effectively combat cancer.Poly lactic-co-glycolic acid (PLGA, 50 mg) nanospheres were constructed with photothermal transduction agents (PTAs)-Prussian blue (PB, 2.98 mg) encapsulated in the core and chemotherapeutic docetaxel (DTX, 4.18 mg)/ immune adjuvant-imiquimod (R837, 1.57 mg) loaded in the shell. Tumor cell membranes were further coated outside PLGA nanospheres (designated "M@P-PDR"), which acted as "Nano-targeted cells" to actively accumulate in tumor sites, and were guided/monitored by photoacoustic (PA)/ magnetic resonance (MR) imaging. Upon laser irradiation, photothermal effects were triggered. Combined with DTX, PTT induced in situ tumor eradication. Assisted by the immune adjuvant R837, the maturation rate of DCs increased by 4.34-fold compared with that of the control. In addition, DTX polarized M2-phenotype tumor-associated macrophages (TAMs) to M1-phenotype, relieving the immunosuppressive TME. The proportion of M2-TAMs decreased from 68.57% to 32.80%, and the proportion of M1-TAMs increased from 37.02% to 70.81%. Integrating the above processes, the infiltration of cytotoxic T lymphocytes (CTLs) increased from 17.33% (control) to 35.5%. Primary tumors and metastasis were significantly inhibited when treated with "Nano-targeted cells"-based cocktail therapy."Nano-targeted cells"-based therapeutic cocktail therapy is a promising approach to promote tumor regression and counter metastasis/recurrence.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
大喜喜发布了新的文献求助10
1秒前
wj发布了新的文献求助10
1秒前
jie完成签到 ,获得积分10
2秒前
li完成签到 ,获得积分10
2秒前
shmilycaleb完成签到,获得积分10
3秒前
景行行止完成签到 ,获得积分10
3秒前
和谐的万宝路完成签到,获得积分10
4秒前
老实惜梦完成签到 ,获得积分10
4秒前
顾矜的应助被前行的灿采纳,获得10
5秒前
gj2221423完成签到 ,获得积分10
6秒前
爆米花的应助被小迪迦奥特曼采纳,获得10
6秒前
YY的应助被钱念波采纳,获得10
7秒前
科研通AI6.4的应助被ad9采纳,获得30
8秒前
新人完成签到,获得积分10
8秒前
无极微光的应助被前行的灿采纳,获得20
9秒前
犹豫的海蓝完成签到,获得积分10
9秒前
10秒前
曦然完成签到 ,获得积分10
11秒前
112233完成签到,获得积分10
11秒前
12秒前
善良梦竹完成签到 ,获得积分10
13秒前
dazhanhongtu01完成签到,获得积分10
13秒前
13秒前
13秒前
13秒前
13秒前
清秀LL完成签到,获得积分10
13秒前
13秒前
今后的应助被科研通管家采纳,获得10
13秒前
NexusExplorer的应助被科研通管家采纳,获得10
13秒前
14秒前
scutljj完成签到,获得积分10
14秒前
寒冷班完成签到,获得积分10
15秒前
酥小苏完成签到,获得积分10
15秒前
Leohp完成签到,获得积分10
15秒前
janejane发布了新的文献求助10
16秒前
兰莓Elena完成签到,获得积分10
16秒前
火蓝完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159174
求助须知:如何正确求助?哪些是违规求助? 9554642
关于积分的说明 21720253
捐赠科研通 7748830
什么是DOI,文献DOI怎么找? 3427184
关于科研通互助平台的介绍 2552091
邀请新用户注册赠送积分活动 2471464